On June 7th, Gelunhui | China Merchants Securities research report pointed out that Aier Eye Hospital Group (300015.SZ) is a global ophthalmology chain medical institution. The company implements a "1+8+N" strategic layout in China, develops central hospitals, promotes the sinking of high-quality medical resources. At the same time, with the implementation of the new decade strategy and the deepening of internationalization, the company's integration of global resource capabilities is continuously improving, and its industry-leading position is further consolidated. Overseas, through the "highland layout" strategy in key regions, the company has achieved synchronization of medical technology with the world. By 2023, the company's overseas business accounted for 10.50%, and the proportion of overseas business will further increase in the future. The bank is optimistic about the company's leading position in the ophthalmology medical services industry for the long term. It will comprehensively promote the entire life cycle of ophthalmology and continuously expand its strategic layout. Against the backdrop of the diversified development of the ophthalmology medical services industry， the competitive advantage is expected to be further reflected. For the first time, it is given a "strong recommendation" investment rating.